A detailed history of Pacer Advisors, Inc. transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 2,507 shares of SLP stock, worth $78,544. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,507
Previous 2,736 8.37%
Holding current value
$78,544
Previous $133,000 39.85%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$30.46 - $46.86 $6,975 - $10,730
-229 Reduced 8.37%
2,507 $80,000
Q2 2024

Aug 13, 2024

BUY
$38.46 - $50.95 $68,574 - $90,843
1,783 Added 187.09%
2,736 $133,000
Q1 2024

May 10, 2024

BUY
$37.48 - $44.74 $17,165 - $20,490
458 Added 92.53%
953 $39,000
Q4 2023

Jan 16, 2024

SELL
$33.36 - $45.71 $3,069 - $4,205
-92 Reduced 15.67%
495 $22,000
Q3 2023

Nov 13, 2023

BUY
$40.03 - $51.51 $2,001 - $2,575
50 Added 9.31%
587 $24,000
Q2 2023

Jul 12, 2023

BUY
$40.45 - $48.0 $21,721 - $25,776
537 New
537 $23,000

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $636M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.